Recombinant multi-species ISG15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ISG15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a ubiquitin-like protein that is conjugated to intracellular target proteins upon activation by interferon-alpha and interferon-beta. Several functions have been ascribed to the encoded protein, including chemotactic activity towards neutrophils, direction of ligated target proteins to intermediate filaments, cell-to-cell signaling, and antiviral activity during viral infections. While conjugates of this protein have been found to be noncovalently attached to intermediate filaments, this protein is sometimes secreted. [provided by RefSeq, Dec 2012]
The Alternative Names of target: G1P2,G1p2,IFI15,IGI15,IMD38,IP17,ISG15,Interferon-induced 15 kDa protein,Interferon-induced 17 kDa protein (IP17),Irfp,Isg15,UCRP,Ubiquitin cross-reactive protein (hUCRP),Ubiquitin-like protein ISG15,hUCRP

Target products collectionGo to ISG15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1038-Ag-1/ GM-Tg-hg-SE1038-Ag-2 Human ISG15 protein Human
GM-Tg-rg-SE1038-Ag-1/ GM-Tg-rg-SE1038-Ag-2 Rat ISG15 protein Rat
GM-Tg-mg-SE1038-Ag-1/ GM-Tg-mg-SE1038-Ag-2 Mouse ISG15 protein Mouse
GM-Tg-cynog-SE1038-Ag-1/ GM-Tg-cynog-SE1038-Ag-2 Cynomolgus/Rhesus macaque ISG15 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1038-Ag-1/ GM-Tg-felg-SE1038-Ag-2 Feline ISG15 protein Feline
GM-Tg-cang-SE1038-Ag-1/ GM-Tg-cang-SE1038-Ag-2 Canine ISG15 protein Canine
GM-Tg-bovg-SE1038-Ag-1/ GM-Tg-bovg-SE1038-Ag-2 Bovine ISG15 protein Bovine
GM-Tg-equg-SE1038-Ag-1/ GM-Tg-equg-SE1038-Ag-2 Equine ISG15 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1038-Ag-1/ GM-Tg-hg-SE1038-Ag-2; GM-Tg-rg-SE1038-Ag-1/ GM-Tg-rg-SE1038-Ag-2;
GM-Tg-mg-SE1038-Ag-1/ GM-Tg-mg-SE1038-Ag-2; GM-Tg-cynog-SE1038-Ag-1/ GM-Tg-cynog-SE1038-Ag-2;
GM-Tg-felg-SE1038-Ag-1/ GM-Tg-felg-SE1038-Ag-2; GM-Tg-cang-SE1038-Ag-1/ GM-Tg-cang-SE1038-Ag-2;
GM-Tg-bovg-SE1038-Ag-1/ GM-Tg-bovg-SE1038-Ag-2; GM-Tg-equg-SE1038-Ag-1/ GM-Tg-equg-SE1038-Ag-2
Products Name ISG15 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ISG15
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ISG15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.